Exscientia PLC (NAS:EXAI)
$ 5.04 -0.16 (-3.08%) Market Cap: 640.18 Mil Enterprise Value: 281.73 Mil PE Ratio: 0 PB Ratio: 1.66 GF Score: 40/100

Exscientia PLC at Barclays Global Healthcare Conference Transcript

Mar 16, 2022 / 03:15PM GMT
Release Date Price: $14.6 (+4.29%)
Peter Richard Lawson
Barclays Bank PLC, Research Division - Research Analyst

Thank you so much. First and foremost, it's absolutely a pleasure to see everybody in person after a 2-year hiatus from COVID, and we're back in person with Barclays event and probably the first for many for the last couple of years as an in-person event for Wall Street and the corporate side as well. So it's an absolute pleasure to see everyone and know the enthusiasm and support again from everyone. So I hope the conference is going well.

My name is Peter Lawson. I'm the moderator of Exscientia's fireside chat. So we've got Andrew Hopkins, CEO; and Ben Taylor, CFO and Chief Strategy Officer.

Questions & Answers

Peter Richard Lawson;Andrew L. Hopkins
Barclays Bank PLC, Research Division - Research Analyst;Exscientia plc - Founder,

I guess the first question I'd love to ask is just like AI within drug discovery, kind of what's the differentiation? How do you differ versus your peers? I know that could probably be a 20-minute answer.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot